 | • レポートコード：MRC-IM30245 • 出版社/出版日：IMARC / 2022年11月 • レポート形態：英文、PDF、143ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥349,860 (USD2,499) | ▷ お問い合わせ |
| Enterprisewide | ￥629,860 (USD4,499) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| グローバル調査会社のIMARC社は、2021年に45.6億ドルであった世界の市販後ファーマコビジランス＆医療情報市場規模が、2022年から2027年の間にCAGR 11.20％で成長し、2027年までに88.2億ドルに達すると予測しています。本調査レポートでは、市販後ファーマコビジランス＆医療情報の世界市場について総合的に調査・分析し、序論、範囲・調査手法、エグゼクティブサマリー、イントロダクション、種類別（自発報告、ADR報告強化、対象限定自発的報告、コホートイベントモニタリング、EHRマイニング）分析、製品別（本、オンラインメディア、ジャーナル）分析、エンドユーザー別（病院、研究機関）分析、地域別（北米、アジア、欧州、中南米、中東・アフリカ）分析、SWOT分析（強み・弱み・機会・脅威）、バリューチェーン分析、ファイブフォース分析、価格分析、競争状況などの項目をまとめています。なお、本書に掲載されている企業情報には、Accenture Plc., ArisGlobal, Cognizant Technology Solutions Corporation, Ergomed Plc, F. Hoffmann-La Roche Ltd., Icon Plc, Parexel International Corporation, Pharmaceutical Product Development, Inc., Wipro Ltd.などが含まれています。 ・序論 ・範囲・調査手法 ・エグゼクティブサマリー ・イントロダクション ・世界の市販後ファーマコビジランス＆医療情報市場規模：種類別 - 自発報告の市場規模 - ADR報告強化の市場規模 - 対象限定自発的報告の市場規模 - コホートイベントモニタリングの市場規模 - EHRマイニングの市場規模 ・世界の市販後ファーマコビジランス＆医療情報市場規模：製品別 - 本の市場規模 - オンラインメディアの市場規模 - ジャーナルの市場規模 ・世界の市販後ファーマコビジランス＆医療情報市場規模：エンドユーザー別 - 病院における市場規模 - 研究機関における市場規模 ・世界の市販後ファーマコビジランス＆医療情報市場規模：地域別 - 北米の市販後ファーマコビジランス＆医療情報市場規模 - アジアの市販後ファーマコビジランス＆医療情報市場規模 - 欧州の市販後ファーマコビジランス＆医療情報市場規模 - 中南米の市販後ファーマコビジランス＆医療情報市場規模 - 中東・アフリカの市販後ファーマコビジランス＆医療情報市場規模 ・SWOT分析（強み・弱み・機会・脅威） ・バリューチェーン分析 ・ファイブフォース分析 ・価格分析 ・競争状況 |
The global post-marketing pharmacovigilance and medical information market size reached US$ 4.56 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 8.82 Billion by 2027, exhibiting a growth rate (CAGR) of 11.20% during 2022-2027.
Post-marketing pharmacovigilance and medical information is the practice of monitoring the safety and efficacy of drugs and medical devices after their launch. It includes collection, surveillance, and prevention of adverse effects of new medicines, equipment, and therapies. It helps protect patients from unnecessary harm by clarifying risks concerning benefits and refuting false indications. Besides this, it assists researchers in determining required actions throughout the drug formulation cycle. As a result, post-marketing pharmacovigilance and medical information finds a considerable role in the healthcare industry to assess the accuracy of the delivered information between patients and medical professionals. It is also used in research organizations for regulating drug safety guidelines.
Post-marketing Pharmacovigilance and Medical Information Market Trends:
The growing global geriatric population and the rising occurrence of various chronic medical disorders, such as diabetes, hypertension, dementia, cardiovascular diseases, and osteoporosis, represent one of the key factors increasing the consumption of medicines. In addition, the increasing frequency of lifestyle, respiratory and cardiovascular infections, and neurological and oncological diseases are resulting in the increasing sales of drugs worldwide. This, in turn, is creating a positive market outlook. In line with this, the rising prevalence of Adverse Drug Reactions (ADRs), coupled with the incorporation of advanced ADR reporting tools, is supporting the market growth. Apart from this, the expansion of hospitals, clinics, laboratories, and medical research centers is catalyzing the demand for medications and medical devices across the globe. Moreover, governments of various countries are implementing several initiatives to improve healthcare infrastructure and pharmacovigilance services and maintain medical databases, which is strengthening the market growth. Furthermore, leading market players are focusing on outsourcing pharmacovigilance operations (PVO) and introducing cloud-based medical information systems for optimal accuracy, cost efficiency, risk mitigation, domain, improved timelines, and organizational agility, which is anticipated to drive the market.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global post-marketing pharmacovigilance and medical information market report, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on type, product and end user.
Breakup by Type:
Spontaneous Reporting
Intensified ADR Reporting
Targeted Spontaneous Reporting
Cohort Event Monitoring
EHR Mining
Breakup by Product:
Books
Online Media
Journals
Breakup by End User:
Hospitals
Research Organization
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Accenture Plc., ArisGlobal, Cognizant Technology Solutions Corporation, Ergomed Plc, F. Hoffmann-La Roche Ltd., Icon Plc, Parexel International Corporation, Pharmaceutical Product Development, Inc. and Wipro Ltd.
Key Questions Answered in This Report:
How has the global post-marketing pharmacovigilance and medical information market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global post-marketing pharmacovigilance and medical information market?
What are the key regional markets?
What is the breakup of the market based on the type?
What is the breakup of the market based on the product?
What is the breakup of the market based on the end user?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global post-marketing pharmacovigilance and medical information market and who are the key players?
What is the degree of competition in the industry?
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Post-marketing Pharmacovigilance and Medical Information Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Type
6.1 Spontaneous Reporting
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Intensified ADR Reporting
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Targeted Spontaneous Reporting
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Cohort Event Monitoring
6.4.1 Market Trends
6.4.2 Market Forecast
6.5 EHR Mining
6.5.1 Market Trends
6.5.2 Market Forecast
7 Market Breakup by Product
7.1 Books
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Online Media
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Journals
7.3.1 Market Trends
7.3.2 Market Forecast
8 Market Breakup by End User
8.1 Hospitals
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Research Organization
8.2.1 Market Trends
8.2.2 Market Forecast
9 Market Breakup by Region
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT Analysis
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Accenture Plc.
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.1.3 Financials
14.3.1.4 SWOT Analysis
14.3.2 ArisGlobal
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.3 Cognizant Technology Solutions Corporation
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.3.3 Financials
14.3.3.4 SWOT Analysis
14.3.4 Ergomed Plc
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.4.3 Financials
14.3.5 F. Hoffmann-La Roche Ltd.
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.5.3 SWOT Analysis
14.3.6 Icon Plc
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.6.3 Financials
14.3.6.4 SWOT Analysis
14.3.7 Parexel International Corporation
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.7.3 SWOT Analysis
14.3.8 Pharmaceutical Product Development, Inc.
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.8.3 SWOT Analysis
14.3.9 Wipro Ltd.
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.9.3 Financials
Figure 2: Global: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Billion US$), 2016-2021
Figure 3: Global: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Billion US$), 2022-2027
Figure 4: Global: Post-marketing Pharmacovigilance and Medical Information Market: Breakup by Type (in %), 2021
Figure 5: Global: Post-marketing Pharmacovigilance and Medical Information Market: Breakup by Product (in %), 2021
Figure 6: Global: Post-marketing Pharmacovigilance and Medical Information Market: Breakup by End User (in %), 2021
Figure 7: Global: Post-marketing Pharmacovigilance and Medical Information Market: Breakup by Region (in %), 2021
Figure 8: Global: Post-marketing Pharmacovigilance and Medical Information (Spontaneous Reporting) Market: Sales Value (in Million US$), 2016 & 2021
Figure 9: Global: Post-marketing Pharmacovigilance and Medical Information (Spontaneous Reporting) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 10: Global: Post-marketing Pharmacovigilance and Medical Information (Intensified ADR Reporting) Market: Sales Value (in Million US$), 2016 & 2021
Figure 11: Global: Post-marketing Pharmacovigilance and Medical Information (Intensified ADR Reporting) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 12: Global: Post-marketing Pharmacovigilance and Medical Information (Targeted Spontaneous Reporting) Market: Sales Value (in Million US$), 2016 & 2021
Figure 13: Global: Post-marketing Pharmacovigilance and Medical Information (Targeted Spontaneous Reporting) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 14: Global: Post-marketing Pharmacovigilance and Medical Information (Cohort Event Monitoring) Market: Sales Value (in Million US$), 2016 & 2021
Figure 15: Global: Post-marketing Pharmacovigilance and Medical Information (Cohort Event Monitoring) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 16: Global: Post-marketing Pharmacovigilance and Medical Information (EHR Mining) Market: Sales Value (in Million US$), 2016 & 2021
Figure 17: Global: Post-marketing Pharmacovigilance and Medical Information (EHR Mining) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 18: Global: Post-marketing Pharmacovigilance and Medical Information (Books) Market: Sales Value (in Million US$), 2016 & 2021
Figure 19: Global: Post-marketing Pharmacovigilance and Medical Information (Books) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 20: Global: Post-marketing Pharmacovigilance and Medical Information (Online Media) Market: Sales Value (in Million US$), 2016 & 2021
Figure 21: Global: Post-marketing Pharmacovigilance and Medical Information (Online Media) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 22: Global: Post-marketing Pharmacovigilance and Medical Information (Journals) Market: Sales Value (in Million US$), 2016 & 2021
Figure 23: Global: Post-marketing Pharmacovigilance and Medical Information (Journals) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 24: Global: Post-marketing Pharmacovigilance and Medical Information (Hospitals) Market: Sales Value (in Million US$), 2016 & 2021
Figure 25: Global: Post-marketing Pharmacovigilance and Medical Information (Hospitals) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 26: Global: Post-marketing Pharmacovigilance and Medical Information (Research Organization) Market: Sales Value (in Million US$), 2016 & 2021
Figure 27: Global: Post-marketing Pharmacovigilance and Medical Information (Research Organization) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 28: North America: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million US$), 2016 & 2021
Figure 29: North America: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 30: United States: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million US$), 2016 & 2021
Figure 31: United States: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 32: Canada: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million US$), 2016 & 2021
Figure 33: Canada: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 34: Asia-Pacific: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million US$), 2016 & 2021
Figure 35: Asia-Pacific: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 36: China: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million US$), 2016 & 2021
Figure 37: China: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 38: Japan: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million US$), 2016 & 2021
Figure 39: Japan: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 40: India: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million US$), 2016 & 2021
Figure 41: India: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 42: South Korea: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million US$), 2016 & 2021
Figure 43: South Korea: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 44: Australia: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million US$), 2016 & 2021
Figure 45: Australia: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 46: Indonesia: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million US$), 2016 & 2021
Figure 47: Indonesia: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 48: Others: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million US$), 2016 & 2021
Figure 49: Others: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 50: Europe: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million US$), 2016 & 2021
Figure 51: Europe: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 52: Germany: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million US$), 2016 & 2021
Figure 53: Germany: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 54: France: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million US$), 2016 & 2021
Figure 55: France: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 56: United Kingdom: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million US$), 2016 & 2021
Figure 57: United Kingdom: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 58: Italy: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million US$), 2016 & 2021
Figure 59: Italy: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 60: Spain: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million US$), 2016 & 2021
Figure 61: Spain: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 62: Russia: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million US$), 2016 & 2021
Figure 63: Russia: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 64: Others: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million US$), 2016 & 2021
Figure 65: Others: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 66: Latin America: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million US$), 2016 & 2021
Figure 67: Latin America: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 68: Brazil: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million US$), 2016 & 2021
Figure 69: Brazil: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 70: Mexico: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million US$), 2016 & 2021
Figure 71: Mexico: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 72: Others: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million US$), 2016 & 2021
Figure 73: Others: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 74: Middle East and Africa: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million US$), 2016 & 2021
Figure 75: Middle East and Africa: Post-marketing Pharmacovigilance and Medical Information Market: Breakup by Country (in %), 2021
Figure 76: Middle East and Africa: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 77: Global: Post-marketing Pharmacovigilance and Medical Information Industry: SWOT Analysis
Figure 78: Global: Post-marketing Pharmacovigilance and Medical Information Industry: Value Chain Analysis
Figure 79: Global: Post-marketing Pharmacovigilance and Medical Information Industry: Porter's Five Forces Analysis